- Home
- OMI vs ARVN Comparison
OMI vs ARVN Comparison
Compare OMI & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- ARVN
- Stock Information
- Founded
- OMI 1882
- ARVN 2015
- Country
- OMI United States
- ARVN United States
- Employees
- OMI N/A
- ARVN N/A
- Industry
- OMI Medical Specialities
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- OMI Health Care
- ARVN Health Care
- Exchange
- OMI Nasdaq
- ARVN Nasdaq
- Market Cap
- OMI 415.6M
- ARVN 456.2M
- IPO Year
- OMI N/A
- ARVN 2018
- Fundamental
- Price
- OMI $5.33
- ARVN $7.74
- Analyst Decision
- OMI Hold
- ARVN Buy
- Analyst Count
- OMI 7
- ARVN 22
- Target Price
- OMI $7.96
- ARVN $20.21
- AVG Volume (30 Days)
- OMI 1.9M
- ARVN 1.4M
- Earning Date
- OMI 11-03-2025
- ARVN 10-29-2025
- Dividend Yield
- OMI N/A
- ARVN N/A
- EPS Growth
- OMI N/A
- ARVN N/A
- EPS
- OMI N/A
- ARVN N/A
- Revenue
- OMI $10,758,440,000.00
- ARVN $372,800,000.00
- Revenue This Year
- OMI N/A
- ARVN $4.87
- Revenue Next Year
- OMI N/A
- ARVN N/A
- P/E Ratio
- OMI N/A
- ARVN N/A
- Revenue Growth
- OMI 64.35
- ARVN 299.57
- 52 Week Low
- OMI $4.56
- ARVN $5.90
- 52 Week High
- OMI $16.47
- ARVN $29.61
- Technical
- Relative Strength Index (RSI)
- OMI 43.33
- ARVN 53.61
- Support Level
- OMI $5.24
- ARVN $7.58
- Resistance Level
- OMI $5.62
- ARVN $8.23
- Average True Range (ATR)
- OMI 0.33
- ARVN 0.38
- MACD
- OMI 0.12
- ARVN 0.01
- Stochastic Oscillator
- OMI 63.74
- ARVN 47.87
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.